This invention relates to an analytical method for the determination of the presence and/or concentration of an analyte in a liquid medium. The method of the present invention is a photoelectrochemical method in which the concentration or the presence of the analyte is determined by means of measurements of a current or voltage, the formation of which is dependent on an enzymatic reaction.
The following references are considered to be pertinent for the purpose of understanding the background of the present invention.
The above publications will be referenced bellow by indicating their number from the above list.
The unique electronic and photonic properties of semiconductor quantum dots have been used in a range of optoelectronic applications.1,2 Specifically, the photophysical features of semiconductor nanoparticles are employed to develop sensor3 and biosensor systems,4-6 light emitting diodes7 and lasers.8,9 Protein functionalized quantum-size semiconductor particles or antibody-modified nanoparticles were suggested as luminescent labels for biorecognition events.10 Similarly, nucleic acid modified semiconductor nanoparticles were reported to act as luminescent probes for DNA hybridization.6,11 Recently, oligonucleotide derivatized quantum dots were used as building blocks to form extended networks of DNA crosslinked nanoparticles, and the photoelectrochemical features of the arrays were examined.12,13 SUMMARY OF THE INVENTION
The present invention provides a method and a device that utilizes functionalized semiconductor element, typically in the form of particles, preferably semiconductor nanoparticles, for detecting presence and/or concentration of an agent in an assayed sample. The semiconductor element has attached thereto an enzyme, which in the presence of a substrate catalyzes a reaction, yielding a product that acts as an electron donor for the holes generated in the valence-band of the semiconductor body by excitation. The analyte is such that it affects the ability of the enzyme to cause generation of the electron donors or the analyte is one of the reactants in the reaction that produces electron donors.
Thus, according to a first aspect, the present invention provides a device comprising:
The device is typically used for assaying an analyte in a sample. In this embodiment, the analyte may be the enzyme's substrate, or may be a modulator of the enzymes activity, e.g. an inhibitor, a co-factor, etc. In the presence of the analyte the electric current may be generated or modulated. This may provide an indication for the presence of the analyte in the assayed sample. The level of the electric current or the extent of the modulation of the electric current may serve as an indication of the concentration of the analyte in the assayed sample. The term “determination” will be used herein to denote both qualitative assaying of the analyte, namely to get a Yes/No answer whether the analyte exists in the assayed sample, as well as a quantitative assaying, namely determine the presence as well as the concentration of the analyte in the sample.
According to a preferred embodiment, the body is an electrode having associated thereto a layer comprising particles made of a semiconducting material, more preferably nanoparticles made of such material. According to another preferred embodiment, the electrode itself is made of or is coated by a semiconducting material. A hybrid system is formed between the semiconducting material and an enzyme, such that upon excitation, e.g. through irradiation with electromagnetic radiation, and in the presence of electron donor, an electric current is generated.
The flow of current is an electric response that results from a reaction occurring in the assayed sample that generates electron donors. The formation of the electron donors is affected by the presence of the analyte in the assayed sample or the analyte itself may be one of the reactants in the reaction. The term “electric response” refers to any measurable change in the electrical parameters recorded by or electrical properties of the electrode. An electric response may be flow of current, charge or potential change that results from the reaction. As will no doubt be appreciated, the invention is not limited by the manner in which the electric response is measured and any manner of measurement that may be used therefor can be applied for measurement of the electric response.
The invention permits the qualitative detection of the presence of an analyte in an assayed sample by monitoring the electric response. In addition, by measuring the extent of the response, the concentration of the analyte may also be quantitatively determined.
Examples of enzymes are acetylcholine esterase (AChE), glucose oxidase, lactate dehydrogenase (LDH), fructose dehydrogenase, alcohol dehydrogenase, malate dehydrogenase, choline oxidase, etc. The electron donor may for example be the reaction product between the enzyme and the substrate, or may be generated from a cofactor of the enzyme. Preferably, the cofactor is either attached through a linker to the semi-conducting material or is solubilized in the assayed sample.
Electrodes in the device of the invention are made of or coated with conducting or semi-conducting materials, for example gold, platinum, palladium, silver, carbon, etc. Semi-conducting materials used in the present invention may be selected, for example, from Group III-V, Group III-V alloys, Group II-VI, Group I-VII, and Group IV semiconductors. Examples of Group III-V semiconductors are InAs, GaAs, GaP, GaSb, InP, InSb, AlAs, AlP, AlSb and alloys such as InGaAs, GaAsP, InAsP. Examples of Group II-VI semiconductors are CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, HgS, HgSe, HgTe and the like. Examples of Group I-VII semiconductors are CuCl, CuBr, CuI, AgCl, AgBr, AgI and the like. Examples of Group IV semiconductors are Si and Ge.
The excitation with electromagnetic radiation may be carried out at diverse wavelengths, depending on the sort of semi-conducting material used and on its form, e.g. particles, nanoparticles, quantum dots, nanorods, etc. For example, in the case of CdS nanoparticles, the excitation energy is in the UV-visible range. The excitation energy may also be tuned by coating the semi-conducting material with a suitable dye.
According to another aspect, the present invention provides a bio-sensing system for determining an analyte in an assayed sample, the system comprising:
Also provided by the present invention, a method for identifying the presence of an analyte in an assayed sample. The method comprises providing a bio-sensing system as defined above, introducing the sample to be assayed into the reaction cell of the system, irradiating the system so as to cause excitation of the semiconducting particles and measuring the electrical response, a change in the electrical response as compared to an electrical response under the same condition in a control medium which does not comprise the analyte, indicating the presence of the analyte in the system.
Also provided by the present invention, a method for measuring the concentration of an analyte in an assayed sample, comprising: providing a bio-sensing system as defined above, introducing the sample to be assayed into the reaction cell of the system, irradiating the system so as to cause excitation of the semi-conducting particles and measuring the electrical response, the magnitude of the electrical response as compared to a calibration curve of the electrical responses under the same conditions in mediums which comprise known concentrations of the analyte, indicating the concentration of the analyte in the system.
According to another aspect, the present invention further provides a bio-sensing system for determining the presence of one or more different analytes in an assayed sample, the system comprising:
In order to understand the invention and to see how it may be carried out in practice, some preferred embodiments will now be described, by way of non-limiting examples only, with reference to the accompanying drawings, in which:
Acetylcholine esterase inhibitors and activators may be detected photoelectrochemically according to the present invention, in a bio-sensing system comprising acetylcholine esterase (AChE) attached covalently or physically to nanoparticles of semi-conducting material such as CdS.
Acetylcholine (ACh) is a central neurotransmitter that activates the synapse and the neural response. The neurotransmitter, ACh, after activating the neural response, is rapidly hydrolyzed by the serine protease ACHE to restore the resting potential of the synaptic membrane. Different reagents, such as the nerve gas diisopropyl fluorophosphate (Sarin) or toxins (e.g. cobratoxin) act as inhibitors or blockers of AChE. Blocking of the enzyme-stimulated nerve conduction leads to rapid paralysis of vital functions of living systems. Thus, the assembly described here may be considered as a biomaterial-semiconductor hybrid device acting as biosensor for biological warfare nerve gases.
CdS nanoparticles (diameter 3 nm) were capped with a protecting monolayer of cysteamine and mercaptoethan sulfonic acid. XPS analysis indicates that ca. 84% of the Cd2+ surface groups are linked to the thiolated molecules and that the ratio between the cysteamine and thiol sulfonate units is ca. 1:10, respectively. The capped CdS nanoparticles were covalently linked to an Au-electrode functionalized with an N-hydroxysuccinimide active ester cysteic acid, as shown in
As depicted in
In further control experiments it was found that the photocurrents generated by the AChE-functionalized CdS monolayer in the presence of different concentrations of the related electron donor cysteamine are similar to the photocurrents generated by the analogous concentrations of acetylthiocholine (1). These results suggest that all of the substrate (1) at the CdS nanoparticle interface is transformed to (2) by the biocatalyzed process, and that the oxidation of (2) by the valence-band holes is efficient and prevents the diffusion of (2) to the bulk solution.
The decrease in the observed photocurrent in the presence of the inhibitor is showed schematically in
In the above example the driving force for the formation of the photocurrent is the biocatalyzed formation of thiocholine that scavenges the photogenerated valence-band holes. It was also demonstrated that enzyme inhibitors decrease the photocurrents, and thus the nanoparticle-AChE system acts as a biosensor for the respective inhibitor. Besides the immediate potential application of such biosensor for biological warfare, the CdS nanoparticle-AChE/acetylthiocholine system may be a versatile photoelectrochemical label for different biosensors.
An additional example includes NAD(P)+ dependent enzymes connected to the CdS nanoparticles. In such examples, the cofactor can be solubilized or immobilized in the system. In the presence of the respective substrate, the enzyme reduces the NAD(P)+ cofactor yielding the respective reduced form NAD(P)H. The reduced cofactor can donate an electron to the CdS nanoparticles, thus maintaining a photocurrent upon the appropriate illumination. The photocurrent will be produced upon the following conditions: (a) CdS nanoparticles are co-immobilized with the NAD(P)+-dependent enzyme at the electrode surface, (b) the respective NAD(P)+ cofactor is added to the solution or co-immobilized in the system, (c) the respective enzyme substrate is added to the solution, (d) appropriate illumination is applied on the electrode surface.
Number | Date | Country | Kind |
---|---|---|---|
153012 | Nov 2002 | IL | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IL03/00795 | 10/2/2003 | WO | 3/6/2006 |